ALFA Filings
Every announcement, straight from the exchange
Every Brawn Biotech other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Brawn Biotech Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026. The filing includes details on promoter and public shareholding.
Brawn Biotech Ltd members approved the appointment of M/s. GDSM and Co. as Statutory Auditors. Mr. Brij Raj Gupta was also re-appointed as Director at the Annual General Meeting.
Brawn Biotech informed the exchange that it has issued letters to shareholders regarding the 41st AGM notice and annual report access.
Brawn Biotech Ltd notified BSE regarding the non-applicability of Regulation 24A for Annual Secretarial Compliance Report. The company remains below the mandatory reporting thresholds for capital and networth.
Brawn Biotech Ltd submitted the compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended March 31, 2026. The Registrar, RCMC Share Registry, confirmed that security certificates received for dematerialisation were processed and mutilated within the required 15-day period.